STOCK TITAN

Nxera Pharma Stock Price, News & Analysis

SOLTF OTC Link

Company Description

Nxera Pharma (OTC Link: SOLTF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $618.5M.

SOLTF stock has gained 6.6% over the past year. Shares last traded at $6.18.

This page provides a comprehensive overview of SOLTF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
+6.64%
Performance 1 year
$618.5M

Nxera Pharma (SOLTF) stock last traded at $6.18. Over the past 12 months, the stock has gained 6.6%. At a market capitalization of $618.5M, SOLTF is classified as a small-cap stock with approximately 92.6M shares outstanding.

SEC Filings

No SEC filings available for SOLTF.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Nxera Pharma (SOLTF) currently stands at 1.6 million shares, down 9.5% from the previous reporting period, representing 2.1% of the float. Over the past 12 months, short interest has decreased by 10.6%. This relatively low short interest suggests limited bearish sentiment. With 126.8 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Nxera Pharma (SOLTF) currently stands at 126.8 days, down 87.3% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 87.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 126.8 to 1000.0 days.

SOLTF Company Profile & Sector Positioning

Nxera Pharma (SOLTF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.

Investors comparing SOLTF often look at related companies in the same sector, including Pharming Group (PHGUF), Oxford Biomedica (OXBDF), Sanbio (SNBOY), Northwest Bio (NWBO), and Cytodyn Inc (CYDY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SOLTF's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Nxera Pharma (SOLTF)?

The current stock price of Nxera Pharma (SOLTF) is $6.185 as of June 5, 2026.

What is the market cap of Nxera Pharma (SOLTF)?

The market cap of Nxera Pharma (SOLTF) is approximately 618.5M. Learn more about what market capitalization means .